Viscoelastic Testing for Assessment of Hypercoagulability and Thrombotic Risk in Cancer Patients: A Systematic Review
Cancers · 03.11.2026 · 18 (21) · 3529
DOI: 10.3390/cancers18213529 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.11.2026. Verfasst von Aleksandra Szymczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Medical University of Gdańsk, 80-210 Gdańsk, Poland. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Viscoelastic assays characterize haemostatic abnormalities in cancer, but their clinical prognostic value remains uncertain. We reviewed thromboelastography (TEG), rapid TEG and rotational thromboelastometry (ROTEM) for laboratory phenotyping and thrombotic risk assessment.
Methods
PubMed/MEDLINE, Embase, Scopus and Web of Science Core Collection were searched through 15 October 2026. During revision, a second reviewer independently verified full-text decisions and extracted data and available quality assessments. Findings were synthesized by temporality, thrombotic endpoint, clinical setting and viscoelastic domain. The protocol was not prospectively registered.
Results
The review included 64 reports published between 1997 and 2026: 38 grouped with clinical thrombotic endpoints and 26 primarily addressing laboratory findings. Forty-five reports used TEG and 19 used ROTEM. Laboratory abnormalities frequently involved faster clot propagation and increased clot strength, but normal or inconsistent profiles were also reported. Associations with existing thrombosis were distinguished from testing before incident events. High discrimination estimates sometimes belonged to multivariable models, while other studies found little independent prognostic information from TEG/ROTEM. Evidence for fibrinolysis-based prediction was limited and assay-dependent.
Conclusions
Evidence supports laboratory haemostatic characterization more strongly than individual thrombosis prediction. Current findings do not establish that viscoelastic-guided thromboprophylaxis improves patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
- Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland.
ORCID-Profile: Franciszek Bałaj, Mariusz Siemiński
Zitieren
APA
Szymczyk, A., Bałaj, F., & Siemiński, M. (2026). Viscoelastic Testing for Assessment of Hypercoagulability and Thrombotic Risk in Cancer Patients: A Systematic Review. Cancers, 18(21), 3529. https://doi.org/10.3390/cancers18213529
Vancouver
Szymczyk A, Bałaj F, Siemiński M. Viscoelastic Testing for Assessment of Hypercoagulability and Thrombotic Risk in Cancer Patients: A Systematic Review. Cancers. 2026;18(21):3529. doi:10.3390/cancers18213529
BibTeX
@article{Szymczyk2026,
author = {Szymczyk, Aleksandra and Bałaj, Franciszek and Siemiński, Mariusz},
title = {Viscoelastic Testing for Assessment of Hypercoagulability and Thrombotic Risk in Cancer Patients: A Systematic Review},
journal = {Cancers},
year = {2026},
volume = {18},
number = {21},
pages = {3529},
doi = {10.3390/cancers18213529}
}
EUVIMED